Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
about
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a reviewDefects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factorsAnti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysisAlanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction.High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion.Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitroInhibition of leukocyte-endothelial interactions by oxidized omega-3 fatty acids: a novel mechanism for the anti-inflammatory effects of omega-3 fatty acids in fish oil.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.High-density lipoproteins: an emerging target in the prevention of cardiovascular disease.Loss-of-function variants influence the human serum metabolomeRosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.Poloxamer 407 as a general lipase inhibitor: its implications in lipid metabolism and atheroma formation in C57BL/6 mice.Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.The effects of PPARγ on the regulation of the TOMM40-APOE-C1 genes cluster.Genetics and molecular biology: a role for adipocyte lipid-binding protein in atherosclerosis.Hypoglycaemia is more frequent in type 2 diabetic patients with co-morbid vascular disease: an analysis of the DiaRegis registry.4',6-Dimethoxyisoflavone-7-O-β-D-glucopyranoside (wistin) is a peroxisome proliferator-activated receptor α (PPARα) agonist in mouse hepatocytes.Dietary Tuna Dark Muscle Protein Attenuates Hepatic Steatosis and Increases Serum High-Density Lipoprotein Cholesterol in Obese Type-2 Diabetic/Obese KK-Ay Mice.
P2860
Q26866784-1384A68B-ACFE-40BB-B499-0846E0D3F5C5Q28207790-3A6CFA14-9FB1-40C4-9983-C34F15FE23A5Q33902895-89CDF4EC-D8A8-416B-9F6B-92E8B0AEE681Q34509923-37BFE158-0E57-45E4-9E01-B072B7D330FFQ34510249-358AD4E3-1270-4A74-9CF0-5738C53A5DB8Q34576530-65C1BE47-F9D0-4F08-8511-0EA995DB02C2Q35081219-D417E01B-D92A-42A0-8801-94BA3C66B016Q36261125-06DD9754-4FD8-4D68-8118-1170D8A321D3Q36611036-76D58FA1-1FD4-4171-910E-570445EAD4AAQ37222510-3E0D2895-8DBD-4A0A-80E3-74621C42D7CFQ37291297-4168EABA-5BB3-46F8-A983-DB29DA710B7CQ37807454-2A4F8D87-73A4-4303-9F17-9BA7162466AFQ38640842-600FEEE5-19DA-4439-BA91-2710931F0260Q38674739-0A6106F9-E996-4D11-A706-5B6CD73C7BDAQ38674742-4561FADC-3227-426A-8EC3-C447CB575751Q38722398-7081A94E-1143-48A2-B17D-0DD386B55A38Q42142650-BD99EB97-93C1-4579-A771-AF8BE0FC4805Q46220548-5E22ACA2-9334-4928-A0E8-2D1EBA7F4D2AQ47215070-379D4D66-A01D-477B-8280-C477B5E8E88CQ51049285-9ED0D574-DCC8-4639-A5F4-89C66D07B4A2
P2860
Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@ast
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@en
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@nl
type
label
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@ast
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@en
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@nl
prefLabel
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@ast
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@en
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@nl
P2860
P1476
Peroxisome proliferator-activa ...... sights for evolving paradigms.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11883-000-0067-3
P577
2000-07-01T00:00:00Z
P6179
1010625601